#1 Clinical Trials Search in Europe
EU – Europe
AT – Austria
HR – Croatia
CZ – Czech Republic
DK – Denmark
EE – Estonia
FI – Finland
FR – France
DE – Germany
IS – Iceland
IT – Italy
LV – Latvia
LT – Lithuania
NL – Netherlands
NO – Norway
PL – Poland
PT – Portugal
RO – Romania
SK – Slovakia
SI – Slovenia
ES – Spain
SE – Sweden
  • Find a Clinical Trial

    Search Trials by Disease

    Non-small cell lung cancer Breast cancer Plasma cell myeloma Neoplasm Neoplasm malignant Acute myeloid leukaemia Colitis ulcerative Obesity Colorectal cancer metastatic Prostate cancer Crohn's disease Colorectal cancer Dementia Alzheimer's type Ovarian cancer Hepatocellular carcinoma Breast cancer metastatic Dermatitis atopic Asthma Non-small cell lung cancer metastatic Malignant melanoma More trials…
  • Rare Diseases Treatments

    Search Trials by Disease

    Desmoid tumour Familial hypertriglyceridaemia Leiomyosarcoma metastatic Bronchiectasis Pulmonary fibrosis Neuroblastoma recurrent Chronic myeloid leukaemia (in remission) Ventricular fibrillation Granulomatosis with polyangiitis Leiomyosarcoma recurrent Primary hyperoxaluria Transient ischaemic attack Retinopathy of prematurity Iron overload Hereditary angioedema More trials…

    Learn about Rare Diseases

    Glycogen storage disease type V – Trials in Disease Friedreich’s ataxia – Diagnostics Mucopolysaccharidosis – Life with Disease Encephalitis autoimmune – Treatment Andersen-Tawil syndrome – Diagnostics Congenital generalised lipodystrophy Choroid melanoma – Basic Information Sarcoma – Treatment Anaplastic thyroid cancer – Diagnostics Factor VIII deficiency – Life with Disease More diseases
  • Vaccine Clinical Trials
  • Pediatric Clinical Trials
  • Resources for Patients

    Browse Innovative Treatments

    Nepafenac Solrikitug Ads-015 Rupatadine Progesterone, Micronised Bosentan ALKYLATING AGENTS Dexchlorpheniramine Clobetasol Ck-0045 Mk-1088 A/(H3N2)-LIKE VIRUS ANTIGEN Losmapimod Benzathine Benzylpenicillin Amcenestrant Paclitaxel Albumin-Bound VERT-002 Brepocitinib Tosilate Ieramilimab HYALURONIDASE More therapies…

    Learn about Your Condition

    Endocarditis Vulvovaginal discomfort Psoriasis Myocarditis post infection Hyperphagia Head injury Radius fracture Lung neoplasm malignant T-cell type acute leukaemia Hyperlipidaemia Rosai-Dorfman syndrome Ebola disease Hysterectomy Erdheim-Chester disease Osteoarthritis More diseases
  • Healthy Volunteers
  • Patient Guide
  • Our Partners
  • About Us
  • Contact us
  • Region
    🇪🇺 Europe
    🇦🇹 Austria
    🇭🇷 Croatia
    🇨🇿 Czech Republic
    🇩🇰 Denmark
    🇪🇪 Estonia
    🇫🇮 Finland
    🇫🇷 France
    🇩🇪 Germany
    🇮🇸 Iceland
    🇮🇹 Italy
    🇱🇻 Latvia
    🇱🇹 Lithuania
    🇳🇱 Netherlands
    🇳🇴 Norway
    🇵🇱 Poland
    🇵🇹 Portugal
    🇷🇴 Romania
    🇸🇰 Slovakia
    🇸🇮 Slovenia
    🇪🇸 Spain
    🇸🇪 Sweden

Digestive System Diseases

  • Patient‑chosen treatment vs routine surgery for adult uncomplicated acute appendicitis: trial of amoxicillin‑clavulanic acid versus appendectomy

    Not yet recruiting

    2 1 1 1
    Investigated Diseases:
    • Appendicitis
    Investigated Drugs:
    • Amoxicillin Sodium
    • Clavulanic Acid
    France

  • Low‑dose human serum albumin versus standard dose during large‑volume paracentesis in patients with liver cirrhosis

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Hepatic cirrhosis
    Investigated Drugs:
    • Human Serum Albumin
    The Netherlands

  • Safety and efficacy of stopping versus maintenance dose of filgotinib, tofacitinib and upadacitinib in adult ulcerative colitis patients in deep remission

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Colitis ulcerative
    Investigated Drugs:
    • Filgotinib
    • Tofacitinib
    • Upadacitinib
    France

  • Switch maintenance with paclitaxel, ramucirumab and tislelizumab versus continued chemotherapy with tislelizumab in HER2‑negative, PD‑L1‑positive gastroesophageal cancer

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Oesophageal adenocarcinoma
    Investigated Drugs:
    • Ramucirumab
    • Tislelizumab
    • Calcium Folinate
    Germany Italy Spain

  • Tacrolimus for prevention of post-ERCP pancreatitis in moderate- to high-risk patients

    Not yet recruiting

    3 1 1
    Investigated Drugs:
    • Tacrolimus
    The Netherlands

  • Evaluation of gaxilose (LacTEST 0.45 g) as a marker of intestinal barrier integrity in patients with celiac disease

    Not yet recruiting

    3 1 1 1
    Investigated Diseases:
    • Coeliac disease
    Investigated Drugs:
    • GAXILOSE
    Spain
Previous Page
1 … 45 46 47 48 49 … 93
Next Page

Investigational Drugs in This Location

See which drug candidates are part of clinical trials near you. Click for detailed trial information.

Medical Conditions Being Studied in This Location

Explore diseases currently included in clinical trials near you. Click to view trials and details for each condition.

European Clinical Trials Information Network

The European Clinical Trials Information Network is transforming access to clinical trial information for patients across Europe. By overcoming language barriers, our platform allows everyone, regardless of their native language, to easily find relevant and comprehensible clinical trial data. This innovative service connects patients to cutting-edge treatments, creating a unified European community where health and progress transcend borders.

This service is not affiliated with the European Commission, the EMA, or the official CTIS system. Most information comes from publicly available international clinical-trial registries, supplemented by data from academic centres, national regulators, and commercial sponsors. We aim to keep all content accurate and up to date.

Explore the full ecosystem of clinical research in Europe.

The information provided on this website is mainly derived from international public clinical trial databases (CTIS.eu). In addition, we are including supplementary sources, such as information provided by academic centers and national regulators, as well as information supplied by commercial sponsors (pharmaceutical companies and contract research organizations). We try to ensure that the information provided is accurate and up to date.

Certain content and visual elements on this website have been generated or enhanced using artificial intelligence (AI).

The website is published by:
CTIN POLAND sp. z o.o.
with its registered office in Warsaw,
ul. rtm. Witolda Pileckiego 67/109,
02-781 Warsaw, Poland,
entered in the Register of Entrepreneurs of the National Court Register under KRS number 0001111334,
REGON: 528919042, NIP (Tax ID): 9512598637
Contact us

© 2026 CTIN Poland

Privacy Policy

Terms and Conditions

Contact

For Sites and Sponsors

Clinical Trial Locations

We use cookies

The website uses cookies to ensure the proper functioning of the site and to analyze internet traffic. Some cookies are essential for using the service and do not require consent. You can accept all cookies or use only the essential ones. Data is processed in accordance with our Privacy Policy. You have the right to withdraw your consent, access, rectify, delete, or limit the processing of your data at any time.
Numer nieprawidłowy!
Numer nieprawidłowy!